Publicité
Publicité

CRMD

CRMD logo

CorMedix Inc.

7.63
USD
Sponsorisé
+0.12
+1.57%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

7.63

0.00
-0.04%

CRMD Rapports sur les bénéfices

Ratio de surprise positive

CRMD a dépassé 25 des 40 dernières estimations.

63%

Prochain rapport

Date du prochain rapport
23 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$130.07M
/
$0.85
Variation implicite de Q3 25 (Revenue/ EPS)
+24.74%
/
-32.54%
Variation implicite de Q4 24 (Revenue/ EPS)
+316.78%
/
+286.36%

CorMedix Inc. earnings per share and revenue

On 12 nov. 2025, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 million, compared to an expected 87.74 million, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analystes forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 million USD, implying an baisse of -32.54% EPS, and hausse of 24.74% in Revenue from the last quarter.
FAQ
For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.
The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.
The next earning report is scheduled for 23 mars 2026.
Based on 9 analystes, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité